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ABSTRACT 1 
Farnesoid X receptor (FXR, NR1H4) plays an important role in the regulation of bile acid 2 
homeostasis in liver and intestine, and may exert protective effects against certain forms of 3 
cancer such as colon carcinoma. However, the role of FXR in cell growth regulation, 4 
apoptosis and carcinogenesis is still controversial. Similar to FXR, microRNA-192 (miR-192) 5 
is mainly expressed in the liver and colon, and plays an important role in the pathogenesis of 6 
colon carcinoma. In this study, we investigated the extent to which FXR is regulated by miR-7 
192. Two in silico-predicted binding sites for miR-192-3p within the NR1H4-3′ untranslated 8 
region (UTR) were examined in vitro by luciferase reporter assays. Wild-type and mutated 9 
forms of the NR1H4-3′UTR were subcloned into a pmirGlo vector and co-transfected into 10 
Huh-7 cells with miR-192-3p. To study the effects of miR-192 on the expression of FXR, 11 
FXR target genes and cell proliferation, Huh-7 and Caco-2 cells were transfected with miR-12 
192-5p and -3p mimics or antagomirs. In addition, the correlation between FXR and miR-192 13 
expression was studied by linear regression analyses in colonic adenocarcinoma tissue from 14 
27 patients. MiR-192-3p bound specifically to the NR1H4-3′UTR and significantly decreased 15 
luciferase activity. Transfection with miR-192 led to significant decreases in NR1H4 mRNA 16 
and protein levels as well as the mRNA levels of the FXR-inducible bile acid transporters 17 
OSTα-OSTβ and OATP1B3. Significant inverse correlations were detected in colonic 18 
adenocarcinoma between NR1H4 mRNA and miR-192-3p expression. In summary, 19 
microRNA-192 suppresses the expression of FXR and FXR target genes in vitro and in vivo. 20 
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INTRODUCTION 25 
Nuclear farnesoid X receptor (FXR, NR1H4) is a ligand-activated transcription factor that 26 
plays a crucial role in the regulation of bile acid, cholesterol, lipid and glucose homeostasis. It 27 
is mainly expressed in the liver, intestines, kidney, and adrenal glands [34]. FXR regulates 28 
key genes involved in human bile acid synthesis and metabolism, including bile acid 29 
transporters [4]. Studies on FXR knockout mice have shown that FXR exerts hepatoprotective 30 
effects. Diminished FXR expression has been linked to an increase in inflammatory responses 31 
and neoplastic transformation in mice [7,16]. Mice lacking FXR expression show elevations 32 
in serum and hepatic bile acid levels and a higher incidence of hepato(cholangio)cellular 33 
carcinoma [12,33]. In mouse intestine, loss of FXR and subsequent elevations of intestinal 34 
bile acid concentrations lead to earlier mortality caused by increased tumor progression via 35 
promotion of Wnt signaling. FXR may play a key role in the intestinal defense against 36 
potentially toxic bile acids by regulating their transport, detoxification, and neosynthesis 37 
[8,23]. Decreased FXR expression levels in human colon cancer tissue compared with non-38 
neoplastic tissue are associated with adverse clinical outcome [15]. In contrast, strongly 39 
enhanced FXR expression, leading to altered expression of FXR-regulated drug uptake 40 
transporters, confers chemoresistance in cancer patients [22]. The role of FXR in cell growth 41 
regulation, apoptosis and carcinogenesis is controversially discussed in the literature. An 42 
immunohistochemical study, for example, showed preserved or enhanced FXR protein 43 
expression in tumor cell nuclei of human hepatocellular carcinoma tissue compared with 44 
hepatocyte nuclei of normal and diseased liver [14].  45 
MicroRNAs (miRs) are short non-coding RNA molecules of 18–25 nucleotides in length, 46 
which repress specific target mRNAs by degradation or translational repression [2]. Two 47 
important liver-specific miRNAs are miR-122, which is estimated to comprise 70% of the 48 
total hepatic miR pool in adults, and miR-192 [28]. The gene encoding hsa-miR-192 is 49 
located on chromosome 11. In addition to expression in the liver, miR-192 is found in the 50 
kidneys and gastrointestinal tract [20]. Elevated serum levels of miR-192 have been detected 51 
in various liver-associated diseases, including drug-induced liver injury, non-alcoholic 52 
steatohepatitis, cholangiocarcinoma, and hepatitis-B-related hepatocellular carcinoma, and 53 
may serve as a biomarker [24,26,28,31,37]. Thus, several studies have hypothesized that 54 
tissue-specific chronic inflammation may trigger increases in miR-192 expression, as in non-55 
alcoholic steatohepatitis [21,24,26]. Because miR-192 shows an inverse correlation with the 56 
metastatic potential of colon cancer cells, miR-192 has been suggested to be a predictive 57 
biomarker for the risk of developing liver metastasis in colon carcinoma. In vivo studies in 58 
mice suggest that miR-192 targets B-cell lymphoma 2 (BCL2), zinc-finger E-box-binding 59 
homeobox 2 (ZEB2), and vascular endothelial growth factor A (VEGFA), all of which are 60 
important anti-apoptotic and angiogenic regulators [9]. The tumor suppressor protein p53 can 61 
act as a transcription factor within the miR-192 promoter, whereas miR-192 itself appears to 62 
suppress carcinogenesis by promoting p21 accumulation [3,27]. Loss of p53 functions by 63 
mutation and consequently decreased expression of miR-192 has been suggested to be a key 64 
step in colon carcinogenesis [3,11,25,29]. Although, miR-192 is not considered to be a 65 
typically dysregulated microRNA in several studies on hepatocellular carcinoma (HCC), Lian 66 
et al. showed a significantly suppressed expression of miR-192 in HCC tissue as compared to 67 
non-tumorous tissue [19]. An important role of miR-192 targeting ZEB2 mRNA has also been 68 
found in HCC [13]. In contrast, certain forms of cancer, such as cholangiocarcinoma and 69 
esophageal cancer, show increased miR-192 expression during carcinogenesis [21,26]. 70 
In this study, we investigated to what extent miR-192 modulates the expression of FXR and 71 
thereby affects the expression of FXR target genes in liver and colon cancer-derived cell lines.  72 
 73 
 74 
MATERIAL AND METHODS 75 
Bioinformatics. An in silico search for possible miRNA-binding sites in the 3′ untranslated 76 
region (UTR) of the NR1H4 gene was performed using miRANDA (Memorial Sloan-77 
Kettering Cancer Center, New York, NY, USA), DIANA-microT-CDS (Biomedical Science 78 
Research Center Alexander Fleming, Athens, Greece), and miRBase (Faculty of Life Science, 79 
University of Manchester, Manchester, UK). mRNA and miR expression data from 27 colonic 80 
adenocarcinoma tissue samples (E-GEOD-29623, Affymetrix GeneChip Humane Genome 81 
U133 Plus 2.0 and NIH Taqman microRNA Array v.2 [5]) were retrieved from the openly 82 
accessible platform ArrayExpress (EMBL-European Bioinformatics Institute, Wellcome Trust 83 
Genome Campus, Hinxton, UK).  84 
 85 
Cell culture. The human hepatoma derived Huh-7 and colon carcinoma derived Caco-2 cell 86 
lines (American Type Culture Collection, Molsheim, France) were cultured in RPMI-1640 87 
and Dulbecco's modified Eagle's medium (Life Technologies, Carlsbad, CA, USA), 88 
respectively, supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO, 89 
USA), 100 U/ml penicillin, and 100 μg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). 90 
Primary human hepatocytes (PHHs) obtained from three patients suffering from primary or 91 
secondary liver carcinoma (ethical approval by the Local Ethical committee of the University 92 
of Munich, Germany, and the Ethics Committee of the Canton of Zurich, Switzerland) were 93 
isolated from the cancer-adjacent normal tissue and cultured as described [17]. PHHs were 94 
kept in maintenance medium including ultraglutamine for 5 h before further procedures. Cell 95 
cultures were incubated at 37°C in a humidified atmosphere with 5% CO2.  96 
 97 
Transient transfection with miR-192. To investigate the effect of miR-192 on NR1H4 98 
mRNA and protein expression, Huh-7 and Caco-2 cells were seeded in 12-well plates (8×104 99 
and 4×105 cells/ml, respectively). After 24 h, cells were transfected with 100 nM hsa-100 
mirVANA® miRNA mimics or Anti-miR™ miRNA inhibitors (hsa-miR-192-3p/-5p and 101 
corresponding negative controls, Life Technologies) using Lipofectamine® RNAiMax diluted 102 
in Opti-MEM I (both purchased from Invitrogen) at a final concentration of 3 mM. Hsa-miR-103 
1 and its known suppressive effect on twinfilin-1 (TWF-1) expression were used as a positive 104 
control. After 4 h of incubation, the transfection medium was replaced with fresh complete 105 
growth medium. At 24, 48 and 72 h after transfection, total mRNA and protein were isolated 106 
using Trizol® reagent (Life Technologies) and RIPA buffer [50 mM Tris HCl pH 8, 150 mM 107 
NaCl, 1% NP-40, 0.5% sodium deoxycholate (all from Sigma-Aldrich), 1 mM EDTA 108 
(Pharmacia Biotech, Uppsala, Sweden), 0.1% SDS, and 10% glycerol (both from Sigma-109 
Aldrich)], respectively. FXR mRNA and protein were quantified in three independently 110 
performed experiments.  111 
To examine miR-192-dependent expression of FXR target genes, Huh-7 cells were treated 112 
with 50 µM chenodeoxycholic acid (CDCA) (Sigma-Aldrich) for 24 h. Data obtained were 113 
merged from four experiments, and the three most representative values were averaged. To 114 
prove that miR-192 mimics control the expression of FXR target genes through FXR 115 
regulation, 100 nM FXR small interfering RNA (siRNA) or corresponding negative control 116 
(Life Technologies) were transfected simultaneously with the miRNA mimics for 48 h. 117 
 118 
Reverse transcription and quantitative real-time PCR. Extracted RNA (1.5 µg) was 119 
transcribed into cDNA by a High Capacity cDNA Reverse Transcription Kit (Applied 120 
Biosystems, Waltham, MA, USA) according to the manufacturer’s protocol. A total of 2 μl of 121 
1:5 diluted cDNA was mixed with 8 μl RT-PCR Universal Fast Master Mix (Applied 122 
Biosystems) including specific primers (TaqMan® Gene Expression Assays NR1H4, 123 
SLCO1B3, SLC51A, and SLC51B; Life Technologies) and subjected to real-time PCR. β-actin 124 
was used as an internal control. To measure miR expression, 10 ng of extracted RNA was 125 
reverse transcribed into cDNA using a TaqMan® miRNA Reverse Transcription Kit (Applied 126 
Biosystems) and specific stem-loop reverse transcription primers (TaqMan® MicroRNA 127 
Assays hsa-miR-192-3p and hsa-miR-192-5p; Life Technologies). RT-PCR was performed 128 
using 0.67 µl cDNA and 9.3 µl RT-PCR Universal Fast Master Mix (Applied Biosystems) 129 
including primers. U6snRNA was used as an internal control. Mean miR expression in three 130 
passages of cells were analyzed per cell line. All measurements were performed in triplicate. 131 
 132 
Western blot analysis. Protein samples (17–30 µg) were diluted 1:5 with loading buffer, 133 
denatured, and separated by 8% SDS-polyacrylamide gel electrophoresis. The separated 134 
proteins were transferred to polyvinylidene fluoride membranes and preincubated for 1 h in 135 
blocking buffer and then for 16 h with the primary antibodies (anti-FXR, Santa Cruz 136 
Biotechnology, Dallas, TX, USA; anti-β-actin, Abcam, Cambridge, UK) at 4°C. After four 137 
washing steps, the membranes were incubated with a horseradish peroxidase-conjugated 138 
secondary antibody (goat-anti-rabbit, Thermo Scientific, Waltham, MA, USA) for 1 h at room 139 
temperature. Protein bands were visualized using SuperSignal® West Femto Maximum 140 
Sensitivity Substrate (Thermo Scientific) and Fusion FX7 (Vilber Lourmat, Eberhardzell, 141 
Germany). β-actin was used as a housekeeping gene. 142 
 143 
Transient cotransfection with miR-192-3p (miR-192*) and NR1H4 3′UTR plasmid 144 
constructs, and luciferase reporter assays. To examine the NR1H4 3′UTR as a target of 145 
miR-192-3p in vitro, luciferase assays were performed using a pmiRGLO Dual-Luciferase 146 
miRNA Target Expression Vector (Promega, Fitchburg, WI, USA), containing both the 147 
coding sequences of firefly luciferase and Renilla luciferase (internal control). The NR1H4 148 
3′UTR (accession number: NG_029843.1) was cloned into the pmiRGLO vector system using 149 
specific primers (Table 1). Plasmids were verified by Sanger sequencing. Huh-7 cells were 150 
seeded in 48-well plates (1.6×105 cells/ml). After 24 h, the cells were transfected with 50 nM 151 
hsa-mirVANA® miRNA mimics or a negative control (hsa-miR-192-3p, Negative Control #1; 152 
Life Technologies) and 100 ng/well of plasmid DNA using Lipofectamine® 2000 153 
(Invitrogen). The activities of firefly and Renilla luciferases were measured at 24 h after 154 
cotransfection using the Dual-Luciferase® Reporter 1000 Assay System (Promega) according 155 
to the manufacturer’s protocol. Hsa-miR-21-5p and its effect on the miR-21 target sequence 156 
were used as a positive control. Analysis was performed using the GloMax® Multi Detection 157 
System (Promega). An empty PmiRGLO vector was used as a background control. 158 
QuikChange Multi Site-Directed Mutagenesis and QuikChange II XL Site-Directed 159 
Mutagenesis Kits (Agilent Technologies, Santa Clara, CA, USA) were used to introduce 160 
mutations into the miR-192-3p-binding sites using specific primers (Table 1). Three 161 
independent luciferase reporter assays were performed including wild-type and mutated target 162 
sequences.  163 
 164 
Cell proliferation and invasion assays. Cell proliferation was determined by the 165 
alamarBlue® (ThermoScientific) cell viability reagent according to the manufacturer’s 166 
instructions. Briefly, Huh-7 and Caco-2 cells were seeded in 96-well plates (7.5×104 and 167 
2×105 cells/ml, respectively). After 24 h, cells were transfected with 100 nM miR-192 168 
mimics, FXR siRNA or the corresponding negative controls. After 48, 72 and 96 h 10 µl of 169 
Alamar Blue was added to each well and cells were incubated for 4 h at 37°C. The absorbance 170 
was determined at 560/600nm using GloMax® Multi Detection System.  171 
Cell invasion was determined with extracellular matrix-coated invasion chambers (QCMTM 172 
24-well cell invasion assay, Millipore, Billerica, MA, USA) according to the manufacturer’s 173 
instructions. Huh-7 and Caco-2 cells were harvested and resuspended in serum-free medium 174 
after pretreatment for 48 h with miR-192 mimics or negative control (cell density for 175 
transfection: 1x105 and 4x105 cells/ml, respectively). Then, 1x105 cells were plated into the 176 
invasion chamber, whereas the bottom well of the chamber contained 500 ul of the 177 
corresponding medium supplemented with 10% FBS. After 48 h of incubation, the invaded 178 
cells on the underside of the membrane were detached, lysed and stained with CyQuant® GR 179 
Dye (Millipore). Fluorescence was measured using a 490/510-570 filter set and GloMax® 180 
Multi Detection System.  181 
 182 
Statistical analysis. Paired one-sample t-tests were performed to compare the effects of miR-183 
192 mimics, antagomirs, FXR siRNA and the corresponding negative controls on FXR 184 
mRNA/protein expression levels and on cell proliferation/invasion. Luciferase activities were 185 
compared between miR-192-3p- and mock-transfected cells by one-way analysis of variance. 186 
All data obtained from transfection experiments were compared with negative control (NC) 187 
mimics or inhibitors, in which expression levels in mock-transfected cells were defined as 1 188 
(except for cell proliferation assays, where values were normalized to the 48h time point of a 189 
particular condition). In general, the negative controls were not expected to bind to the 190 
NR1H4 3′UTR or to block the activity of endogenously expressed miR-192. Only experiments 191 
with verified positive controls were included in statistical analyses. The association between 192 
FXR and miR-192 expression levels was investigated in 27 colonic adenocarcinoma tissue 193 
samples by linear regression analyses excluding subjects that had undergone chemotherapy 194 
(E-GEOD-29623 [5]). Values are shown as averages ± standard deviation. A p value of less 195 
than 0.05 was considered to be statistically significant. Statistical analyses were performed 196 
using R-Software (version 2.15.2) and Graph Pad Prism (version 5.04). 197 
 198 
 199 
RESULTS 200 
The mature forms of pre-miR-192 derived from the 5′ and 3′ strands of the precursor 201 
are detectable in Huh-7 and Caco-2 cells. The online database miRBase lists two mature 202 
sequences for the human miRNA precursor pre-miR-192, miR-192-5p, and miR-192-3p. 203 
Quantitative measurement of the endogenous expression levels showed the presence of both 204 
strands at considerable amounts in Huh-7, PHH and Caco-2 cells. MiR-#-3p was expressed 205 
10-fold less in Huh-7 cells, 32-fold less in Caco-2 cells, and 39-fold less in PHH cells 206 
compared with miR-#-5p. Furthermore, miR-192-3p showed a 9 to 10-fold higher expression 207 
in Caco-2 cells than in the hepatoma cell line or the primary human hepatocytes (data not 208 
shown). 209 
  210 
Confirmation of the NR1H4 3′UTR as a target of miR-192-3p by luciferase reporter 211 
assays. The software tools miRANDA and DIANA-microT-CDS predicted binding of miR-212 
192-3p to NR1H4 transcript positions 199–227 and 324–352 (position relative to translational 213 
stop codon, NG_029843.1, Fig. 1A). No binding site within the NR1H4 3′UTR was predicted 214 
for miR-192-5p. Cotransfection of miR-192-3p mimics and the NR1H4 3′UTR target 215 
sequence into Huh-7 cells resulted in a 30% decrease in luciferase activity compared with the 216 
empty vector control (p<0.01). In contrast, luciferase activity remained unaffected by 217 
cotransfection of the NR1H4 3′UTR target sequence carrying the miR-192 binding sites in the 218 
mutated form compared with the wild-type construct (Fig. 1B), indicating a negative 219 
interaction of miR-192-3p with the predicted binding sites in the NR1H4 3′UTR.  220 
 221 
MiR-192 attenuates endogenous NR1H4 mRNA levels in Huh-7 and Caco-2 cells. To 222 
investigate the effect of miR-192 on endogenous FXR expression levels, Caco-2 and Huh-7 223 
cells were transfected with 100 nM miR-192-3p or -5p mimics for 24 or 48 h. As shown in224 
Fig. 2A, NR1H4 mRNA levels were repressed to 75% and 65% by miR-192-3p and -5p 225 
mimics, respectively, in Huh-7 cells (p<0.05). In Caco-2 cells, a decrease by 15% and 28% in 226 
NR1H4 mRNA expression was detected after transfection with miR-192-3p and -5p mimics 227 
for 24 h (p<0.05). To examine whether transfection of an antagomir could reverse the 228 
endogenous miR-192-dependent inhibitory effect on FXR expression, Caco-2 and Huh-7 cells 229 
were transfected with 100 nM anti-miR-192 inhibitors for 24 or 48 h, respectively. As shown 230 
in Fig. 2B, NR1H4 mRNA levels were increased significantly by anti-miR-192-3p inhibitors 231 
in Caco-2 cells as well as anti-miR-192-5p inhibitors in Huh-7 cells compared with the anti-232 
miR miRNA inhibitor negative control (p<0.05). Thus, the miR-192-dependent effect on FXR 233 
regulation appeared to be stronger in Huh-7 cells compared with Caco-2 cells. 234 
 235 
MiR-192 suppresses FXR protein translation in Huh-7 and Caco-2 cells. Consistent with 236 
the miRNA-dependent effects on NR1H4 mRNA expression, a 63% decrease in FXR protein 237 
expression was seen after transfection with miR-192-3p mimic in Huh-7 cells (p<0.05). 238 
Weaker downregulation by 14% was observed after transfection of miR-192-5p. A decrease 239 
by 14% and 43% in FXR protein expression was observed in Caco-2 cells after transfection 240 
with miR-192-3p and -5p, respectively (Fig. 3A). As shown in Fig. 3B, the endogenous miR-241 
192-dependent suppressive effect on FXR protein expression was reversed upon transfection 242 
with anti-miR-192-3p or -5p inhibitors. In Huh-7 cells, an increase in FXR protein levels was 243 
not seen following transfection of the miR-192-3p antagomir, which could be explained by 244 
the lower expression of the 3′ in relation to the 5′ strand in Huh-7 compared to Caco-2 cells.  245 
MiR-192 suppresses the expression of key FXR target genes. The bile acid transporters 246 
organic-anion transporting polypeptide 1B3 (OATP1B3, SLCO1B3) and organic solute 247 
transporters α/β (OST alpha/beta, SLC51A/B) were chosen as model genes to examine the 248 
effect of miR-192 on FXR-regulated expression of transport proteins. Huh-7 cells were 249 
transfected with 100 nM miR-192-3p or -5p for 48 h. 24 h after transfection, cells were 250 
treated with 50 µM CDCA for 24 h to activate FXR and compared with the miRNA mimic 251 
negative control. As shown in Fig. 4, SLCO1B3, SLC51A and SLC51B mRNA levels were 252 
decreased by either one or both strands of miR-192, suggesting a reduction of gene 253 
transcription secondary to reduced expression of the transcriptional activator FXR. This was 254 
confirmed by simultaneous FXR knockdown and miRNA transfection experiment (data not 255 
shown).  256 
 257 
Linear regression analyses reveal an inverse association between the expression levels of 258 
miR-192 and FXR in colonic adenocarcinoma. To investigate whether the in vitro effects of 259 
miR-192 on FXR expression were reproducible in vivo, we analyzed 27 tissue samples from 260 
chemotherapy-untreated patients with primary colonic adenocarcinoma (Table 2). As shown 261 
in Table 32 and Fig. 5, a significant inverse association in expression was observed for the 262 
NR1H4 mRNA transcript coding for FXRα2(+) and hsa-miR-192-3p. FXRα2 isomers 263 
represent the most abundantly expressed FXR protein forms in colonic tissue, whereas the 264 
isomer FXRα1 is predominantly expressed in liver [30]. No significant associations were 265 
found for NR1H4 mRNA and hsa-miR-192-5p expression, showing that the 5’ strand does not 266 
confer pronounced NR1H4 mRNA degradation in vivo. These findings support the regulatory 267 
effects of miR-192 on FXR expression in hepatoma and colon cancer-derived cell lines 268 
observed in vitro.  269 
MiR-192 exhibits suppressive effects on proliferation of Huh-7 and Caco-2 cells. To 270 
investigate the functional significance of the observed miR-192/FXR interaction, we 271 
performed cell proliferation assays using Alamar Blue. As shown in Fig. 6, transfection with 272 
miR-192-3p mimic significantly reduces proliferation of Huh-7 and Caco-2 cells, whereby a 273 
stronger effect could be observed in the hepatoma cell line. These findings confirm the 274 
previously described suppressive effects of miR-192 on proliferation of the colon cancer cell 275 
lines HT-29, RKO and HCT116 [27]. Knockdown of FXR expression causes similar anti-276 
proliferative effects in Huh-7 cells. In contrast, reduction in FXR expression does not seem to 277 
have any influence on the proliferative potential of Caco-2 cells. By performing cell invasion 278 
assays, we saw a trend towards a suppressive effect for both strands of the miR-192 precursor 279 
molecule on cell invasion of Huh-7 cells, however the results were not significant (data not 280 
shown). In a previous work, Lian et al. showed that miR-192 could significantly downregulate 281 
cell invasion of Huh-7 cells [19].   282 
 283 
284 
DISCUSSION 285 
The aim of this study was to investigate whether FXR is a target of miR-dependent, post-286 
transcriptional gene regulation. Regulation of FXR expression by miR-421 as an oncogenic 287 
miR in biliary tract cancer has already been postulated [36]. Our results show an additional, as 288 
yet uncharacterized role of miR-192 in regulating FXR expression.  289 
Our in vitro experiments elucidated the inhibitory effect of miR-192 on FXR expression by 290 
transfecting colon and liver cell lines with miR-192 mimics and inhibitors. In the case of the 291 
3′ strand, we found a significant miR-192-dependent inhibitory effect on NR1H4/FXR mRNA 292 
and protein expression in Huh-7 cells, whereas in Caco-2 cells only transfection with the anti-293 
miR-192-3p inhibitor showed a relevant effect. A possible explanation for the observed 294 
weaker inhibitory effect of the miR-192-3p mimic in Caco-2 cells, compared with that in 295 
Huh-7 cells, may be the more abundant expression of miR-192 in the colon cell line. The 296 
observed miR-192*-dependent effects on NR1H4 mRNA levels in both cell lines and our in 297 
vivo findings that showed a strong inverse miR-192* and FXRα2(+) correlation in colonic 298 
adenocarcinoma support our hypothesis of a strong endogenous effect of miR-192 on FXR 299 
expression. Degradation of NR1H4 mRNA transcripts can be explained by perfect 300 
complementary interference of the miR-192-3p seed sequence at the two in silico-predicted 301 
binding positions of the NR1H4-3′UTR. The 5′ strand of miR-192 also appeared to repress 302 
FXR gene expression in vitro, albeit through a different mechanism. Transfections with the 303 
corresponding antagomirs support our findings with both mimics in our model cell lines.  304 
According to the miRBase database, about 80 different human miRNA precursors can yield 305 
two abundant mature miRNAs, i.e. the 5′ strand (miR-#-5p) and 3′ strand (miR-#-3p) with 306 
different seed sequences and mRNAs as binding targets. There is increasing evidence for 307 
interplay between the 5′ and 3′ strands of the same precursor molecule targeting the same 308 
group of genes, thereby reinforcing a certain phenotype [10], which can be supported by our 309 
data.  310 
Hsa-miR-192 has been shown to play a crucial role in the pathogenesis of colon carcinoma, 311 
the third most common cancer in Western countries [6]. Because of its cancer stage-312 
dependent decline in expression, miR-192 has been suggested to be a potential biomarker to 313 
predict metastasis in colon carcinoma patients [9]. Our findings regarding the inverse 314 
association of FXR and miR-192* expression in colonic cancer patients suggest that this 315 
miRNA-dependent mechanism of FXR regulation could play an important role in 316 
carcinogenesis. We additionally showed that miR-192 can suppress expression of the bile acid 317 
and anticancer drug transporter OATP1B3 and the bile acid transporter OSTα/β in a FXR-318 
dependent manner.  319 
It remains unclear whether restoration of miR-192 expression and the consequently 320 
diminished expression of FXR target genes would be beneficial for cancer patients, especially 321 
considering that miR-192 has been shown to possibly act as an oncogenic miRNA by 322 
downregulation of Smad interacting protein 1 in other inflammation-related cancers 323 
[21,26,35]. Therefore, it can be speculated that diminished expression of the transport protein 324 
OSTα/OSTβ, a heterodimer-forming bile acid transporter important for the excretion of bile 325 
acids from hepatocytes and enterocytes, may be a mechanism of intracellular bile acid 326 
accumulation promoting inflammation and/or cancer development in certain cases. 327 
By performing cell proliferation and invasion assays, we were able to confirm the previously 328 
described suppressive role of miR-192 in liver and colon cancer progression. We observed a 329 
miR-192-associated anti-proliferative effect in Huh-7 cells that is stronger than in Caco-2 330 
cells, where no noteworthy effects of the 3’ strand arm could be seen on FXR protein levels. 331 
Furthermore, knockdown of FXR did not show any influence on Caco-2 cell proliferation. 332 
These observations support the hypothesis that the anti-proliferative effect of mR-192-3p may 333 
be to some extent FXR-dependent. Future studies have to elucidate to what extent the miR-334 
192/FXR interplay supports or inhibits tumor pathogenesis. Our results are in line with reports 335 
showing that enhanced FXR expression and the associated altered expression of FXR-336 
regulated drug-uptake transporters is related to chemoresistance in cancer patients. Treatment 337 
of the colorectal adenocarcinoma cell line LS174T with cisplatin leads to a cisplatin-resistant 338 
phenotype that is accompanied by a 350-fold increase in FXR expression [22]. Furthermore, 339 
increased expression of OATP1B3 has been suggested to confer anti-apoptotic resistance to 340 
paclitaxel by altering p53-dependent pathways [18]. 341 
It may be of value to confirm the detected association between miR-192 and FXR expression 342 
in larger cohorts. We cannot exclude the contribution of other miRs or epigenetic factors to 343 
FXR regulation. However, a further step would be to systematically test all in silico-predicted 344 
miRs for effects on the NR1H4-3′UTR. 345 
In conclusion, miR-192-5p and -3p negatively regulate the expression of FXR in a synergistic 346 
manner, thereby significantly decreasing the expression of FXR target genes OSTα/β and 347 
OATP1B3. We show a new miR-dependent mechanism of FXR regulation, which could 348 
affect the expression of FXR target genes and plays a role in the pathogenesis of liver and 349 
colon cancers and their response to anticancer therapies. 350 
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 500 
 501 
FIGURE LEGENDS 502 
Fig. 1. (A) Predicted binding sites for the seed sequence of miR-192-3p in the 3′UTR of 503 
NR1H4 mRNA using the bioinformatic tool miRANDA (www.microrna.org). (B) Relative 504 
reporter gene activities at 24 h after cotransfection of Huh-7 cells with the wild-type NR1H4-505 
3′UTR target clone or mutated NR1H4-3′UTR target clone. The miR target clone control 506 
vector was used for normalization. Experiments were performed as triplicates and repeated 507 
three times. ** p < 0.01, ns = not significant.  508 
 509 
Fig. 2. Effect of miR-192-5p and -3p mimics (A) and inhibitors (B) on NR1H4 mRNA 510 
expression in Huh-7 and Caco-2 cells at 48 h and 24 h, respectively, after transfection. 511 
NR1H4 mRNA expression relative to β-actin was determined by real-time PCR. The miR 512 
mimic/inhibitor negative control (NC) was used for normalization. Experiments were repeated 513 
three times. * p < 0.05, ns = not significant. 514 
 515 
Fig. 3. Effect of miR-192-5p and -3p mimics on FXR protein expression in Huh-7 cells at 72 516 
h after transfection and in Caco-2 cells at 48 h after transfection (A). Anti-miRNA-dependent 517 
effect on FXR protein levels (B). Caco-2 and Huh-7 cells were treated with anti-miR-192-5p 518 
and -3p inhibitors for 48 and 72 h. FXR protein expression relative to β-actin was determined 519 
by western blotting and densitometry. Bands of one representative blot are shown for each 520 
condition and cell line. Experiments were repeated three times. ** p < 0.01, * p < 0.05, ns = 521 
not significant. 522 
 523 
Fig. 4. Effect of miR-192-5p and -3p mimics on mRNA expression of key FXR target genes 524 
important for bile acid homeostasis in Huh-7 cells at 48 h after transfection. SLCO1B3, 525 
SLC51A, and SLC51B mRNA expression relative to β-actin was determined by real-time 526 
PCR. The miR mimic negative control (NC) was used for normalization. Experiments were 527 
repeated four times. *** p < 0.001, ** p < 0.01, * p < 0.05, ns = not significant. 528 
 529 
Fig. 5. Correlation between FXR and miR-192 expression in colonic adenocarcinoma-derived 530 
tissue samples from 27 patients by linear regression analysis. A significant inverse association 531 
was detected for miR-192-3p and the NR1H4 mRNA transcript coding for FXRα2(+) 532 
(coefficient = -1.57/ p = 0.0259). 533 
 534 
Fig. 6. Impact of miR-192-5p and -3p (A/C) or FXR siRNA (B/D) on proliferation of Huh-7 535 
and Caco-2 cells using Alamar Blue assay. 48h values of each condition were used for 536 
normalization. Experiments were repeated four times. *** p < 0.001, ** p < 0.01,* p < 0.05. 537 
 538 
 539 
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 545 
TABLE LEGENDS 546 
Table 1. Primer sequences used for subcloning and mutagenesis. Recognition sites for the 547 
restriction enzymes are underlined in the primers used for subcloning. In silico-predicted 548 
binding sites for hsa-miR-192-3p are underlined in the mutagenesis primers, whereas 549 
mutations inserted into these sites are indicated in bold. FXRwt_miR192* primers were used 550 
to optimize the second binding site for miR-192-3p.  551 
 552 
Table 2. Clinical characteristics of the 27 patients showing primary colonic adenocarcinoma 553 
who were included into linear regression analysis. 554 
 555 
Table 32. Linear regression analysis of hsa-miR-192-3p with the NR1H4 mRNA transcripts 556 
coding for FXRα2(+) and FXRα1(-), and miR-192-5p expression in primary colonic 557 
adenocarcinoma tissue obtained from 27 patients. miR-192-3p inversely correlates with 558 
FXRα2(+) expression.   559 
 560 
Table 3. Clinical characteristics of the 27 patients showing primary colonic adenocarcinoma 561 
who were included into linear regression analysis. 562 
 563 
 564 
 565 
 566 
 567 
Table 1: Primer sequences used for subcloning and mutagenesis 
 
 
Table 2: Linear regression analysis of miR-192-3p expression with FXRα2(+), FXRα1(-), 
and miR-192-5p expression in primary colonic adenocarcinoma 
Transcript Coefficient Std. Error  P-Value 
FXRα2(+) -1.57 0.66  2.59E-02 
FXRα1(-) 1.87 0.70  1.39E-02 
hsa-miR-192-5p 0.31 0.14  4.13E-02 
Adjusted R-squared: 0.348
568 
Oligonucleotide Sequence (5’ – 3’) Purpose 
FXR_3UTR_FW aggagctctggggattacaggggagg  Subcloning of NR1H4 
3’prime end into pmirGlo 
FXR_3UTR_RV aggtcgacgccaagattgaatacaactct  Subcloning of NR1H4 
3’prime end into pmirGlo 
FXRmut_miR192*_FW1 ggaatcctgcattctagtcgccgagccctgtttgcctaattaaattg  Multi-site directed 
mutagenesis 
 
FXRmut_miR192*_FW2 gagttgtattcaatctggccgtcgacctaatcccgcggc 
 
Multi-site directed 
mutagenesis 
 
FXRwt_miR192*_FW gagttgtattcaatcttggcagtcgacctaatcccgcggc 
 
Site-directed mutagenesis 
FXRwt_miR192*_RV gccgcgggattaggtcgactgccaagattgaatacaactc Site-directed mutagenesis 
Table 23: Clinical characteristics of 27 patients with primary colonic adenocarcinoma 
Parameters Category N(%) 
Gender male 
female 
15(55.6) 
12(44.4) 
AJCC stage pT1 
pT2 
pT3 
pT4 
6(22.2) 
13(48.2) 
4(14.8) 
4(14.8) 
Tumor grade 1 
2 
3 
3(11.1) 
20(74.1) 
4(14.8) 
Treatments Chemotherapy-naive 27(100) 
569 
570 
Table 3: Linear regression analysis of miR-192-3p expression with FXRα2(+), FXRα1(-), 
and miR-192-5p expression in primary colonic adenocarcinoma 
Transcript Coefficient Std. Error  P-Value 
FXRα2(+) -1.57 0.66  2.59E-02 
FXRα1(-) 1.87 0.70  1.39E-02 
hsa-miR-192-5p 0.31 0.14  4.13E-02 
Adjusted R-squared: 0.348
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572 
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